Opsoclonus-myoclonus syndrome: a clinicopathological confrontation

被引:0
作者
Baets, J.
Pals, P.
Bergmans, B.
Foncke, E.
Smets, K.
Hauman, H.
Vanderwegen, L.
Cras, P.
机构
[1] Univ Antwerp, Dept Neurol, Born Bunge Fdn, Lab Neurobiol & Neuropathol, B-2610 Antwerp, Belgium
[2] Heilig Hartziekenhuis, Dept Neurol, Lier, Belgium
[3] St Maarten Gen Hosp, Dept Neurol, Duffel, Belgium
[4] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium
关键词
paraneoplastic syndrome; breast carcinoma; NSCLC; immunoglobulins; plasmapheresis;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Opsoclonus-myoclonus syndrome (OMS), a movement disorder characterised by chaotic eye movements and myoclonus, is a rare clinical entity. We present two cases of opsoclonus-myoclonus syndrome of paraneoplastic origin. In the first patient the syndrome was associated with a breast carcinoma and in the second patient with a non small cell lung carcinoma. However none of the commonly associated antibodies were found in these cases. From the neuropathological findings from the first patient we find arguments that support the current hypothesis on the pathophysiology of OMS namely a dysfunction in brainstem and cerebellum. We conclude that in adults with OMS one has to be very suspicious of a possible neoplastic origin of the syndrome. The antibodies associated with some cases of OMS are thought to play a role in the pathophysiology of the syndrome although the exact immunologic mechanism remains unknown. Research into the neuropathological substrate of OMS yields a broad range of abnormalities in brain stem and cerebellum. However none of these findings seem to be pathognomonic. As for the possible therapy of OMS, several immunomodulating strategies can be used with varying success. At present there is no established standard therapy.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 23 条
  • [1] Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus
    Bataller, L
    Graus, F
    Saiz, A
    Vilchez, JJ
    [J]. BRAIN, 2001, 124 : 437 - 443
  • [2] Autoantigen diversity in the opsoclonus-myoclonus syndrome
    Bataller, L
    Rosenfeld, MR
    Graus, F
    Vilchez, JJ
    Cheung, NKV
    Dalmau, J
    [J]. ANNALS OF NEUROLOGY, 2003, 53 (03) : 347 - 353
  • [3] Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome
    Blaes, F
    Fühlhuber, V
    Korfei, M
    Tschernatsch, M
    Behnisch, W
    Rostasy, K
    Hero, B
    Kaps, M
    Preissner, KT
    [J]. ANNALS OF NEUROLOGY, 2005, 58 (02) : 313 - 317
  • [4] THE MOVEMENT DISORDER OF ADULT OPSOCLONUS
    CAVINESS, JN
    FORSYTH, PA
    LAYTON, DD
    MCPHEE, TJ
    [J]. MOVEMENT DISORDERS, 1995, 10 (01) : 22 - 27
  • [5] CHER LM, 1995, CANCER-AM CANCER SOC, V75, P1678, DOI 10.1002/1097-0142(19950401)75:7<1678::AID-CNCR2820750719>3.0.CO
  • [6] 2-2
  • [7] Childhood opsoclonus myoclonus
    Dale, RC
    [J]. LANCET NEUROLOGY, 2003, 2 (05) : 270 - 270
  • [8] Opsoclonus-myoclonus associated with celiac disease
    Deconinck, N
    Scaillon, M
    Segers, V
    Groswasser, JJ
    Dan, B
    [J]. PEDIATRIC NEUROLOGY, 2006, 34 (04) : 312 - 314
  • [9] ANTINEURONAL (ANTI-RI) ANTIBODIES IN A PATIENT WITH STEROID-RESPONSIVE OPSOCLONUS-MYOCLONUS
    DROPCHO, EJ
    KLINE, LB
    RISER, J
    [J]. NEUROLOGY, 1993, 43 (01) : 207 - 211
  • [10] Paraneoplastic neurological disorders in breast cancer
    Gatti, G
    Simsek, S
    Kurne, A
    Zurrida, S
    Naninato, P
    Veronesi, P
    Frasson, A
    Millen, E
    Rososchansky, J
    Luini, A
    [J]. BREAST, 2003, 12 (03) : 203 - 207